openPR Logo
Press release

Pharmacovigilance and Drug Safety Software Market: Pharmacovigilance and Drug Safety Software Market: Major Insights

Pharmacovigilance and Drug Safety Software Market:

The global pharmacovigilance and drug safety software market is projected to create new opportunities in the coming years on account of the escalating complexity of drug safety regulations. Among the key contributing factors of the market could be tighter regulatory inspections implemented to control the rise of the incidences of drug-associated adverse events and spiraling concerns pertaining to patient safety.

Pharmaceutical and biotechnology companies are predicted to largely adopt pharmacovigilance software for curbing the burden on medical outlay and facilitating clinical trial programs. The fortifying growth of contract research organizations (CROs) that perform pharmacovigilance for pharma firms could also strengthen the growth of the global pharmacovigilance and drug safety software market.

Obtain Report Details @https://www.transparencymarketresearch.com/pharmacovigilance-drug-safety-software-market.html

As per Transparency Market Research (TMR), the global pharmacovigilance and drug safety software market could earn a US$187.0 mn by 2022 end after advancing from a US$143.6 mn achieved in 2017 at a CAGR of 5.4%.

Global Pharmacovigilance and Drug Safety Software Market: Major Insights

The world pharmacovigilance and drug safety software market is envisaged to gain momentum from crucial applications in clinical research for performing post-marketing surveillance roles and conducting clinical studies. On a global platform, some of the most commonly used pharmacovigilance software could be Argus and ArisG. The benefits that such software bring to the table, including decreased redundancy in data and ease of access, could strongly fuel the demand in the market. In the foreseeable future, the usage rate of pharmacovigilance tools is envisioned to receive a good boost due to the rising pressure on drug manufacturers to identify early indications of drug-related adverse interactions and increasing withdrawals of high-profile drugs.

The world pharmacovigilance and drug safety software market is forecasted to be cataloged according to software type, end user, and delivery mode. In terms of segmentation by type of software, fully integrated software, issue tracking software, drug safety audits software, and adverse event reporting software could be prominent markets for pharmacovigilance and drug safety software. The adverse event reporting software market could rise at a 6.2% CAGR.

By end user, the world pharmacovigilance and drug safety software market could see a segmentation into business process outsourcing (BPO) firms, CROs, pharma and biotech companies, and other pharmacovigilance service providers. On the basis of mode of delivery, there could be important segments such as on-premise and cloud-based keeping the hopes alive for growth.

Make an Enquiry @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31112

Geographically, North America could secure a top position in the world pharmacovigilance and drug safety software market while raking in a US$79.2 mn by the end of 2022. Between 2017 and 2022, Europe is prophesied to make its contribution to the market by creating an absolute revenue opportunity that could be greater than that expected to be achieved by Asia Pacific except Japan (APEJ) during the forecast period. Markets such as Japan, Latin America, the Middle East and Africa (MEA) could be other key segments of the market.

Global Pharmacovigilance and Drug Safety Software Market: Vendor Landscape

Some of the crucial companies functioning in the worldwide pharmacovigilance and drug safety software market could be UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal.

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance and Drug Safety Software Market: Pharmacovigilance and Drug Safety Software Market: Major Insights here

News-ID: 794282 • Views: 291

More Releases from Transparency Market Research

Accelerometer Market Future Prospects and Opportunity Assessment Upto 2026
The global Accelerometer market is estimated to attain a valuation of US$ 2,489.6 Mn by the end of 2026, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.046 during the forecast period, 2018 to 2026. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Power Supply Market to Perceive Substantial Growth During 2021-2031
A report by Transparency Market Research (TMR) provides 360-degree analysis of the global Power Supply market. Hence, readers get access to thorough assessment of important factors including the growth drivers, challenges, R&Ds, and business expansion opportunities in the market during the forecast period, 2021 to 2031. The key objective of the report is to offer a complete assessment of the global market including major leading stakeholders of the Power Supply industry.
Multifactor Authentication Market is Booming Across the Globe
Transparency Market Research delivers key insights on the global multifactor authentication market. In terms of revenue, the global multifactor authentication market is estimated to expand at a CAGR of 16.08% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global multifactor authentication market. The global multifactor authentication market is broadly affected by several factors, including increase in adoption of
Crawler Camera System Market Sales in Canada till 2027
Across the globe, different types of crawler camera systems are available in the marketplace. These systems are gaining significance also due to their growing adoption for use in different types of pipeline inspections. Crawler camera systems offer various advantages for use in pipeline inspection, as they have a comfortable grip that is helpful to hold the handheld control console for lengthy operations. Also, they are lightweight, robust, and reliable in

All 5 Releases


More Releases for Pharmacovigilance

Pharmacovigilance Outsourcing Market 2021 | Detailed Report
Pharmacovigilance Outsourcing Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Pharmacovigilance Outsourcing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4964765 The report provides a comprehensive analysis of company profiles listed below: - Clinquest Group B.V - Cognizant - LabCorp - IBM -
Global Pharmacovigilance Market & Forecasts
According to a new market research report published by Global Market Estimates, the Global Pharmacovigilance Market is expected to grow at a CAGR of 13.55% during the forecast period. The demand for pharmacovigilance is projected to be high due to the increasing demand for pharmacovigilance services and rising cost-effective initiatives for SMEs companies. Browse 145 Market Data Tables and 118 Figures spread through 168 Pages and in-depth TOC on "Pharmacovigilance Market
Rising Number of Government Pharmacovigilance Centers to Boost Pharmacovigilance …
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of
Pharmacovigilance Market | Forecast up to 2020
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of
Pharmacovigilance Market Research Report Forecast to 2020
Pharmacovigilance is a crucial component of an effective drug regulation system and is used for evaluating and monitoring adverse drug reactions. Pharmacovigilance activities are essential for conducting clinical research. Currently, the global network of pharmacovigilance centers is operating effectively to assure appropriate functioning of drug safety procedures. The large volume of international adverse drug reaction reports collected and stored in a central database assists the national drug regulatory authorities to
ICRC-Weyer To Enhance Pharmacovigilance Risk Management
The Berlin-based clinical contract research organization (CRO) ICRC-Weyer has made further enhancements to their Pharmacovigilance risk management. By integrating medical review procedures into the Pharmacovigilance system the company is now able to provide efficient risk management strategies in line with current market and regulatory developments. The decision to pursue this integration process was made following ICRC-Weyer’s recent participation at the Evolution Summit in Munich, Germany, an industry forum bringing together representatives